ERA-NET ON CARDIOVASCULAR DISEASES – ERA-CVD - " Mechanisms of early atherosclerosis and/or plaque instability in Coronary Artery Disease."
- Organization:
- European Commission
- Category:
- Projectes de recerca
- Scope:
- International
- Start:
- Internal deadline:
- Official deadline:
- Description:
-
Objectiu de la convocatòria
ERA-CVD is a newly established European Research Area Network (ERA-Net) comprising 23 Partners from 18 countries/regions. The goal of ERA-CVD is to create a European Research Area in which cardiovascular research is conducted and funded across countries, allowing research groups to jointly work on specific problems, exchange ideas, and benefit from cross border expertise.Característiques principals
The JTC 2017 aims at enabling scientists in different countries to build an effective collaboration on common multidisciplinary research projects based on complementarities and sharing of expertise in the field of coronary artery disease, with a clear translational research approach.
Supported projects are expected to have a concrete impact in the early recognition and prognosis of CAD and will be of help at identifying those individuals /patients who will likely develop acute events in the near future (0-12 months).Transnational research proposals must cover at least one of the following two sub-topics, which are equally relevant for this call, in relation to early recognition of CAD:
- exploration of mechanisms leading to plaque instability, including the role of genetic factors, nutritional and gut microbiota giving mechanistic insights into the development, progression or plaque instability;
- improvement of imaging techniques as well as validation of biomarkers (genetic, epigenetic, lipidomic, proteomic, metabolomics, microbiota), leading to earlier recognition of risk and/or protective factors. Biomarkers are characteristics that are measured as an indicator of a biological or pathological process, or of a pharmacological response. Validation studies must provide published data on the sensitivity of the biomarker in question and may apply for further specificity, bio-analytical assessment, probability of false positives or false negatives and Pharmacokinetic-Pharmacodynamic (PK-PD) model validation steps.
Convocatòria (URL)
Informació addicional
Electronic submission system: https://secure.pt-dlr.de/ptoutline/app/eracvd_jtc2017Requisits
Each consortium submitting a proposal must involve a minimum of three (3) and a maximum of five (5) eligible partners. Additionally, eligible partners must come from at least three (3) different countries participating in the call (see list above). A consortium must not involve more than one research group from the same country or region participating in the call, unless the second partner is an associated partner who secures his own funding. As an exception, two (2) research groups from Spain may be comprised in the same research consortium (please see Spanish eligibility conditions).
In order to strengthen the European research area in the field of cardiovascular diseases, a wide inclusion of researchers from all the countries/regions participating in the call is encouraged, with a particular attention to research teams from Estonia, Latvia, Poland, Romania, Slovakia and Turkey. Research consortia including teams from these countries may increase the total number of eligible partners to six (6).
A consortium may include one (1) research group not eligible to the national/regional funding organisations participating in this call or from countries not involved in this call only if this group provides a demonstrable added value to the consortium. Such research group is not considered in the minimum number of three (3) partners mentioned above. At the stage of the pre-proposal submission, this group must confirm that funding for its activities in the project is already secured. The availability of the funding must be documented at the stage of full proposal submission.
Overall, a research consortium can comprise a maximum of seven (7) partners, if including one (1) partner from the above indicated countries (Estonia, Latvia, Poland, Romania, Slovakia and Turkey) and one (1) partner with own funding.
For Spanish applicants: please check the eligibility requirements of the institution and the principal investigator/team members, in pages 29-32 of the Guidelines.Dotació
For Spanish participants:- up to 100,000 € (overheads included) per partner
- up to 150.000 € (overheads included) per coordinator
Durada
- 3 years